Ellen O'Riordan is a news reporter for The Irish Times, with a focus on national news in Ireland. Her articles cover a wide range of topics, including legal cases, property disputes, human rights issues, and government challenges. Ellen's work has also been featured in the Irish Independent.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Ireland (National)
Not enough data
Ellen O'Riordan's coverage is focused on legal and government-related topics, particularly disputes, court decisions, human rights issues, and asylum seeker matters in Ireland. She extensively covers legal policy regulation and government announcements.
If you're reaching out to Ellen with a pitch or as a potential source, consider offering insights into ongoing legal cases, governmental policies related to the topics she often covers. Additionally, if you have expertise in Irish law or politics or can provide analysis of significant court decisions or their implications on human rights issues and asylum seekers in Ireland, your input may be valuable for her coverage.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Ellen O Riordan
Medical Council entitled to have ‘serious concerns' about Michael John Sheill's lack of insight, says judge
By: Ellen O'Riordan
Twitter International takes issue with new Online Safety Code’s approach to “restricted” video content
Company alleges various parts of the 2018 Data Protection Act are contrary to the Constitution
By: Ellen O'Riordan
Mr Justice Michael Twomey is managing the five actions ahead of their trial next spring
By: Ellen O'Riordan
Hearing of cases is scheduled for nine weeks beginning next March
By: Ellen O'Riordan
Court hears man in his 30s has relatively short life expectancy due to Huntington’s disease
By: Ellen O Riordan
Mr Justice Alexander Owens said both of the deceased men were “up to their necks in organised crime”
By: Ellen O Riordan
The High Court and Court of Appeal had already refused to halt the trial
By: Ellen O'Riordan
Judge ‘completely satisfied that significant issues’ of public and patient safety arose to necessitate interim suspension orders
By: Ellen O Riordan
Immedis was sold in July 2023 to American software company Unite Parent Corp in a major deal reportedly worth €575 million
(833) 317-6278 
